The EVERY Company is a Precision Fermentation company founded in 2014 and based in Daly City, United States. It has raised $294M in total funding, most recently a Series D in 2025.
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| Nov 5, 2025 | Series D | $55M | — | McWin Capital Partners |
| Jun 23, 2021 | Series C | $175M | — | McWin, Temasek |
No articles ingested yet for The EVERY Company. Once the hourly news pipeline is live, every article the classifier tags as mentioning this company appears here with its one-line AI summary and sentiment.
A portfolio of animal-free egg proteins made by precision fermentation, in which engineered microbes are programmed to produce egg proteins, including egg-white ovalbumin, without chickens. The proteins are sold as B2B ingredients that food and beverage makers use to deliver the binding, foaming, gelling and protein-fortification functions of conventional egg, with the egg-white protein reaching consumer products on US retail shelves. The line is positioned as a drop-in, allergen- and chicken-free alternative for applications ranging from beverages and protein powders to baked goods.